SANTORO, ARMANDO
 Distribuzione geografica
Continente #
AS - Asia 439
NA - Nord America 366
EU - Europa 96
Continente sconosciuto - Info sul continente non disponibili 43
SA - Sud America 17
AF - Africa 9
Totale 970
Nazione #
US - Stati Uniti d'America 347
SG - Singapore 193
VN - Vietnam 100
CN - Cina 87
FR - Francia 38
BD - Bangladesh 29
IT - Italia 26
BR - Brasile 11
DE - Germania 8
HK - Hong Kong 8
SE - Svezia 7
CA - Canada 6
IE - Irlanda 5
TR - Turchia 4
MX - Messico 3
PH - Filippine 3
PL - Polonia 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
EC - Ecuador 2
ES - Italia 2
FI - Finlandia 2
GB - Regno Unito 2
ID - Indonesia 2
IN - India 2
IQ - Iraq 2
JM - Giamaica 2
LB - Libano 2
PK - Pakistan 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
BB - Barbados 1
CI - Costa d'Avorio 1
CL - Cile 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HN - Honduras 1
KE - Kenya 1
MA - Marocco 1
MU - Mauritius 1
NL - Olanda 1
PA - Panama 1
PS - Palestinian Territory 1
SC - Seychelles 1
VE - Venezuela 1
Totale 927
Città #
Singapore 95
San Jose 68
Council Bluffs 43
Ashburn 39
Lauterbourg 35
Ho Chi Minh City 28
Hanoi 26
Boardman 17
New York 9
Da Nang 8
Beijing 6
Parma 6
Buffalo 5
Chandler 5
Dublin 5
Santa Clara 5
Dallas 4
Los Angeles 4
Nashua 4
Orlando 4
Bologna 3
Charleston 3
Denver 3
Hong Kong 3
Johannesburg 3
Munich 3
Nuremberg 3
Phoenix 3
Thomasville 3
Alexandria 2
Atlanta 2
Bakersfield 2
Baku 2
Blanchard 2
Can Tho 2
Champaign 2
Copenhagen 2
Frankfurt am Main 2
Guangzhou 2
Haiphong 2
Houston 2
Joliet 2
Lewisville 2
Milan 2
Montreal 2
Nanchang 2
Nashville 2
Pensacola 2
Querétaro 2
Sacramento 2
San Antonio 2
San José 2
Sioux Falls 2
Tashkent 2
Toms River 2
Tân Tiến 2
Upper Marlboro 2
Warsaw 2
Abbeville 1
Abidjan 1
Adana 1
Ambato 1
Ankara 1
Ann Arbor 1
Augusta 1
Baghdad 1
Barakaldo 1
Bari 1
Basra 1
Beau Bassin-Rose Hill 1
Beauchamps 1
Beirut 1
Bekasi 1
Bento Gonçalves 1
Biyala 1
Blue Springs 1
Boston 1
Bowie 1
Boynton Beach 1
Brescia 1
Bridgetown 1
Burnaby 1
Bình Phước 1
Bến Tre 1
Cabo Frio 1
Casablanca 1
Castel Volturno 1
Chaguanas 1
Changsha 1
Chennai 1
Chicago 1
Cleveland 1
Cochabamba 1
Contagem 1
Cuatro Cañadas 1
Detroit 1
Easton 1
Edgewood 1
El Paso 1
Esteio 1
Totale 543
Nome #
Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer 119
Assessment of HER2 status in patients with gastroesophageal adenocarcinoma treated with epirubicin-based chemotherapy: heterogeneity-related issues and prognostic implications 41
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection 39
Direct-Acting Antiviral Agents in Hepatitis C–Associated Indolent Lymphomas 34
Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma 31
Emergence of KRAS-mutation in liver metastases after an anti-EGFR treatment in patient with colorectal cancer: are we aware of the therapeutic impact of intratumor heterogeneity? 31
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough? 30
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 27
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study 26
Tivantinib for Second-line Treatment of Advanced MET-High Hepatocellular Carcinoma: A Phase 3, Randomized, Placebo-Controlled Study (METIV-HCC) 26
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma 25
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study 25
Role of stereotactic body radiation therapy in the management of oligometastatic pancreatic cancer single institution experience 24
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma 24
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study 22
Progression of Colorectal Liver Metastases from the End of Chemotherapy to Resection: A New Contraindication to Surgery? 22
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors 22
Pembrolizumab in MMR-proficient metastatic colorectal cancer pharmacologically primed to trigger dynamic hypermutation status: The ARETHUSA trial 22
Budget impact of bimonthly use of cetuximab in patients diagnosed with metastatic colorectal cancer 21
Aggressive and Multidisciplinary Local Approach to Iterative Recurrences of Colorectal Liver Metastases 21
Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer 20
Determinants of Treatment Benefit and Post-Treatment Survival for Patients with Hepatocellular Carcinoma Enrolled in Second-Line Trials after the Failure of Sorafenib Treatment 20
Biomarkers in Hepatocellular Carcinoma-Letter 20
Can stereotactic body radiation therapy be a viable and efficient therapeutic option for unresectable locally advanced pancreatic adenocarcinoma? Results of a phase 2 study 20
COVID-19 and liver cancer clinical trials: not everything is lost 19
Reply to Y. Pointreau et al 19
Prognostic value of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: an exploratory analysis from the second-line ARQ 197-215 study 18
Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection 17
Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND) 17
Standardisation of EGFR FISH in colorectal cancer: results of an international interlaboratory reproducibility ring study 16
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study 16
Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study 16
Regorafenib in hepatocellular carcinoma: latest evidence and clinical implications 15
Cabozantinib for the treatment of hepatocellular carcinoma 15
Sorafenib in hepatitis C-virus negative patients with hepatocellular carcinoma: don’t throw the baby out with the bathwater 11
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomized, placebo-controlled phase 2 study 11
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 11
Tivantinib for hepatocellular carcinoma 11
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib 10
Molecular determinants of outcome in sorafenib-treated patients with hepatocellular carcinoma 10
Regorafenib for the treatment of unresectable hepatocellular carcinoma 10
Usefulness of alpha-fetoprotein response in patients treated with sorafenib for advanced hepatocellular carcinoma 8
The role of hepatic metastases and pulmonary tumor burden in predicting survival after complete pulmonary resection for colorectal cancer 8
Totale 970
Categoria #
all - tutte 4.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.151


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222 0 0 0 0 0 0 0 1 0 0 0 1
2022/202318 3 3 1 1 1 2 0 1 6 0 0 0
2023/20247 0 2 0 0 1 2 0 1 0 0 0 1
2024/202523 0 1 1 3 2 3 0 0 4 1 3 5
2025/2026758 5 4 5 3 104 115 138 83 122 109 47 23
2026/2027149 129 20 0 0 0 0 0 0 0 0 0 0
Totale 970